Filing Details

Accession Number:
0001140361-16-079713
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-09-13 20:27:35
Reporting Period:
2016-09-09
Filing Date:
2016-09-13
Accepted Time:
2016-09-13 20:27:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1428336 Healthequity Inc HQY Services-Business Services, Nec (7389) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1651926 Jon Soldan C/O Healthequity, Inc.
15 W. Scenic Pointe Dr., Ste. 100
Draper UT 84020
Exec Vp, Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-09-09 10,000 $28.69 10,000 No 4 M Direct
Common Stock Disposition 2016-09-09 10,000 $34.31 0 No 4 S Direct
Common Stock Acquisiton 2016-09-12 15,000 $28.69 15,000 No 4 M Direct
Common Stock Disposition 2016-09-12 15,000 $33.04 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2016-09-09 10,000 $0.00 10,000 $28.69
Common Stock Stock Option (right to buy) Acquisiton 2016-09-12 15,000 $0.00 15,000 $28.69
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
90,000 2025-08-26 No 4 M Direct
75,000 2025-08-26 No 4 M Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $24.36 2026-03-23 25,000 25,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2026-03-23 25,000 25,000 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.00 to $34.59, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (1) and (2) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.95 to $33.32, inclusive.
  3. The option is immediately exercisable as to 25,000 shares. The remaining shares become exercisable in three equal annual installments of 25,000 shares on August 26, 2017, 2018 and 2019.
  4. The option becomes exercisable in four equal annual installments on March 23, 2017, 2018, 2019 and 2020.